1612
J.-X. Li, G.-W. Wang / Tetrahedron Letters 53 (2012) 1610–1612
product 2 (27.0 mg, 65%). 1H NMR (300 MHz, CS2/DMSO-d6): d 12.0 (s, 1H),
(C@O), 164.50 (C@O), 149.73, 148.00, 146.91 (1C), 146.75 (1C), 146.03, 145.87,
145.79, 145.69, 145.67, 145.61, 145.31, 145.15, 145.04 (4C), 144.89, 143.91,
143.88, 142.72, 142.50, 142.40, 142.14, 141.91, 141.70, 141.53, 141.31, 141.26,
140.25, 138.96, 135.56, 135.19, 95.11 (1C, C(COC2H5)2), 83.02 (1C, sp3-C of C60),
76.06 (1C, sp3-C of C60), 62.62 (OCH2CH3), 62.57 (OCH2CH3), 52.87 (1C, SCH),
4.40–4.27 (m, 4H), 1.34 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CS2/DMSO-d6
with Cr(acac)3 as relaxation reagent, all 2C unless indicated): d 197.70 (1C,
C@S), 163.75 (C@O), 150.22, 147.34, 146.92, 145.90 (1C), 145.47 (1C), 144.74,
146.63, 144.54, 144.32, 144.29, 143.96 (4C), 143.81, 143.63, 143.51, 142.95,
142.52, 141.19, 141.13, 141.10, 140.82, 140.78, 140.33, 140.14, 139.93, 139.75,
138.76, 137.09, 134.90, 132.16, 81.51 (1C), 81.24 (1C, sp3-C of C60), 69.27 (1C,
13.88 (OCH2CH3), 13.86 (OCH2CH3); FT–IR m
/cmꢀ1 (KBr): 2976, 1742, 1618,
1462, 1441, 1367, 1295, 1258, 1168, 1137, 1090, 1025, 863, 577, 527; UV–vis
(CHCl3) kmax (nm): 256 (5.00), 315 (4.48), 427 (3.37), 686 (2.51); MS (ꢀESI): m/
z 1095 (Mꢀ). Compound 5d: 1H NMR (300 MHz, CDCl3) d 6.30–6.16 (m, 1H),
5.51 (d, J = 16.9 Hz 1H), 5.32 (d, J = 10.0 Hz, 1H), 4.53–4.36 (m, 4H), 4.27 (d,
J = 7.0 Hz, 2H), 1.38 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3, with Cr(acac)3
as relaxation reagent) (all 2C unless indicated): d 175.79 (1C, C@N), 167.13
(C@O), 150.37, 149.05, 147.23 (1C), 147.08 (1C), 146.35, 146.31, 146.18,
146.08, 145.98, 145.91, 145.51, 145.47, 145.34 (4C), 145.23, 144.23, 144.21,
143.03, 142.80, 142.70, 142.46, 142.23, 141.95, 141.86, 141.67, 141.64, 140.44,
139.32, 135.57, 135.54, 132.23 (1C, CH@CH2), 119.37 (1C, CH@CH2), 95.91 (1C,
C(COC2H5)2), 84.03 (1C, sp3-C of C60), 76.19 (1C, sp3-C of C60), 62.95 (OCH2CH3),
sp3-C of C60), 61.79 (OCH2CH3), 12.96 (OCH2CH3), FT–IR /cmꢀ1 (KBr) 3451,
m
2976, 1750, 1496, 1463, 1366, 1297, 1259, 1214, 1171, 1137, 1092, 1049, 858,
578, 527; UV–vis (CHCl3) kmax (nm) (log
e) 2.56 (4.95), 315 (4.45), 428 (3.28),
686 (2.30); MS (ꢀESI): m/z 937 (Mꢀ).
16. Compound
2
(14.8 mg, 0.016 mmol) was added to
a
mixture of CS2-THF
L of water, the reaction mixture was vigorously
stirred at room temperature for 2 days, compound was converted to
(16.5 mL, 10:1) containing 10
l
2
compound 3 quantitatively. After evaporation of solvents, the residue was
separated on a silica gel column with CS2/THF as the eluent to give compound 3
(13.4 mg, 92%). 1H NMR (300 MHz, CS2/DMSO-d6): d 10.19 (s, 1H), 4.33 (q,
J = 7.1 Hz, 4H), 1.33 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CS2/DMSO-d6 with
Cr(acac)3 as relaxation reagent, all 2C unless indicated): d 169.07 (1C, C@O),
165.38 (C@O), 150.09, 148.13, 146.49, 146.15 (1C), 145.64 (1C), 145.38, 145.03,
144.98, 144.69, 144.65, 144.28 (4C), 144.14, 143.96, 143.89, 143.22, 142.86,
141.64, 141.44, 141.42, 141.10, 140.98, 140.71, 140.46, 140.39, 140.14, 139.54,
137.46, 135.19, 133.65, 74.55 (1C), 73.09 (1C, sp3-C of C60), 68.93 (1C, sp3-C of
35.15 (1C, SCH2), 14.08 (OCH2CH3); FT–IR
1461, 1428, 1365, 1259, 1229, 1126, 1085, 1039, 922, 889, 865, 576, 527; UV–
vis (CHCl3) kmax (nm): (log ) 257 (5.02), 313 (4.52), 427 (3.37), 688 (2.30); MS
m
/cmꢀ1 (KBr): 2975, 1741, 1604,
e
(ꢀESI): m/z 977 (Mꢀ). Compound 5e: 1H NMR (300 MHz, CS2/DMSO-d6): d
4.36–4.25 (m, 4H), 2.91 (s, 3H), 1.34 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CS2/
DMSO-d6 with Cr(acac)3 as relaxation reagent, all 2C unless indicated): d
174.63 (1C, C@N), 164.88 (C@O), 149.50, 148.06, 145.88 (1C), 145.75 (1C),
145.19, 145.03, 144.97, 144.85, 144.65, 144.59, 144.26, 144.20, 144.03, 143.99,
143.88, 143.01, 142.92, 141.77, 141.53, 141.42, 141.22, 140.94, 140.68, 140.56,
140.42, 140.39, 139.12, 137.88, 134.31, 134.09, 94.52 (1C, C(COC2H5)2), 82.48
(1C, sp3-C of C60), 75.04 (1C, sp3-C of C60), 61.35 (OCH2CH3), 14.45 (1C, SCH3),
C60), 61.80 (OCH2CH3), 13.22 (OCH2CH3); FT–IR
1722, 1462, 1438, 1365, 1296, 1250, 1227, 1179, 1089, 1009, 859, 763, 575,
m
/cmꢀ1 (KBr) 3386, 2974, 1747,
527; UV–vis (CHCl3) kmax (nm) (log
e) 2.56 (4.96), 313 (4.43), 427 (3.31), 686
(2.30); MS (ꢀESI) m/z 921 (Mꢀ).
17. Typical procedure for the synthesis of 5a–g:
A
mixture of
2
(9.4 mg,
L) was
0.01 mmol), 4a (0.02 mmol, 0.04 mmol for 4b–g), and Et3N (50
l
13.30 (OCH2CH3); FT–IR m
/cmꢀ1 (KBr): 2976, 1740, 1605, 1462, 1427, 1365,
stirred in CS2 (10 mL) at room temperature for 30 min. Then the solution
was separated on a silica gel column with CS2/ethyl acetate as the eluent to
1260, 1130, 1088, 1039, 890, 865, 730, 577, 527; UV–vis (CHCl3) kmax (nm)
(log
e
): 256 (4.95), 313 (4.43), 427 (3.28), 690 (2.31); MS (ꢀESI): m/z 951 (Mꢀ).
give product 5a–g. Compound 5a: 1H NMR (300 MHz, CDCl3)
d
8.20 (d,
Compound 5f: 1H NMR (300 MHz, CDCl3) d 4.42 (q, J = 7.2 Hz, 4H), 3.16 (s, 3H),
1.36 (t, J = 7.2 Hz, 6H); 13CNMR (75 MHz, CS2/CDCl3, with Cr(acac)3 as
relaxation reagent) (all 2C unless indicated): d 200.80 (1C, C@S), 175.27 (1C,
C@O), 164.59 (C@O), 150.80, 147.62 (1C), 147.53, 147.45, 147.26 (1C), 146.39,
146.34, 145.99 (4C), 145.78, 145.50, 145.43, 145.32, 145.27, 145.14, 144.44,
144.10, 142.73 (6C), 142.30 (4C), 141.83, 141.78, 141.34, 141.09, 140.44,
139.09, 136.81, 134.01, 85.05 (1C, C(COC2H5)2), 84.72 (1C, sp3-C of C60), 68.09
(1C, sp3-C of C60), 63.45 (OCH2CH3), 27.59 (1C, CH3), 13.90 (OCH2CH3); FT–IR
J = 8.8 Hz, 2H), 7.04 (d, J = 8.8 Hz, 2H), 5.14 (s, 2H), 4.48–4.32 (m, 4H), 3.93 (s,
3H), 1.34 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CDCl3, with Cr(acac)3 as
relaxation reagent) (all 2C unless indicated) d 191.73 (1C, C@O), 175.88 (1C,
C@N), 167.12 (C@O), 164.29 (1C, aryl C), 150.28, 148.94, 147.38 (1C), 147.19
(1C), 146.47, 146.43, 146.31, 146.15, 146.09, 146.04, 145.66, 145.62, 145.47
(4C), 145.34, 144.35, 144.32, 143.13, 142.92, 142.83, 142.55, 142.38, 142.11,
141.96, 141.77, 141.73, 140.65, 139.40, 135.77, 135.72, 131.33 (aryl C), 128.76
(1C, aryl C), 114.14 (aryl C), 95.84 (1C, C(COC2H5)2), 83.92 (1C, sp3-C of C60),
76.49 (1C, sp3-C of C60), 63.08 (OCH2CH3), 55.71 (1C, OCH3), 40.48 (1C, SCH2),
(KBr)
m
/cmꢀ1: 2978, 2923, 1764, 1743, 1513, 1434, 1365, 1268, 1240, 1222,
):
1142, 1085, 1014, 863, 780, 615, 594, 527; UV–vis (CHCl3) kmax (nm) (log
e
14.14 (OCH2CH3); FT–IR
1440, 1424, 1262, 1172, 1136, 1088, 1036, 830, 578, 527; UV–vis (CHCl3) kmax
(nm) (log
m
/cmꢀ1 (KBr): 2925, 1740, 1673, 1599, 1511, 1462,
255 (5.01), 316 (4.57), 428 (3.32), 682 (2.39); MS (+ESI): m/z 1002 (M+Na+).
Compound 5g: 1H NMR (300 MHz, CS2/CDCl3) d 8.19 (d, J = 7.8 Hz, 2H), 7.64 (t,
J = 7.4 Hz, 1H), 7.53 (t, J = 7.5 Hz, 2H), 4.48–4.37 (m, 4H), 1.33 (t, J = 7.2 Hz, 6H);
13C NMR (75 MHz, CS2/CDCl3, with Cr(acac)3 as relaxation reagent, all 2C unless
indicated): d 201.73 (1C, C@S), 172.54 (1C, C@O), 164.52 (C@O), 150.71, 147.32
(3C), 147.04, 146.96 (1C), 146.20, 146.10, 145.77 (6C), 145.61, 145.28, 145.08
(4C), 144.91, 144.27, 143.87, 142.53 (6C), 142.08 (4C), 141.66, 141.51, 141.30,
140.92, 140.35, 138.73, 137.13, 133.92, 133.41 (1C, aryl C), 132.87 (1C, aryl C),
129.96 (aryl C), 128.53 (aryl C), 84.54 (1C, C(COC2H5)2), 83.72 (1C, sp3-C of C60),
e
): 257 (5.00), 312 (4.53), 427 (3.33), 689 (2.29); MS (ꢀESI): m/z 1085
(Mꢀ). Compound 5b: 1H NMR (300 MHz, CDCl3) d 4.48–4.36 (m, 4H), 4.40 (s,
2H), 1.56 (s, 9H), 1.37 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CDCl3, with
Cr(acac)3 as relaxation reagent) (all 2C unless indicated) d 175.42 (1C, C@N),
167.01 (C@O), 166.90 (1C, C@O), 150.29, 148.88, 147.29 (1C), 147.13 (1C),
146.37, 146.33, 146.23, 146.09, 146.03, 145.96, 145.57, 145.55, 145.39 (4C),
145.27, 144.26 (4C), 143.06, 142.85, 142.75, 142.49, 142.28, 142.02, 141.89,
141.70, 141.65, 140.53, 139.35, 135.75, 135.60, 95.81 (1C, C(COC2H5)2), 83.76
(1C, sp3-C of C60), 82.80 (1C, OC(CH3)3), 76.41 (1C, sp3-C of C60), 63.00
69.18 (1C, sp3-C of C60), 63.43 (OCH2CH3), 13.79 (OCH2CH3), FT–IR (KBr)
2922, 1748, 1721, 1449, 1359, 1298, 1252, 1193, 1087, 1078, 1009, 774, 717,
685, 651, 527; UV–vis (CHCl3) kmax (nm) (log ) 255 (5.07), 317 (4.64), 428
(3.43), 683 (2.63); MS (+ESI) m/z 1064 (M+Na+).
m
/cmꢀ1
(OCH2CH3), 36.01 (1C, SCH2), 28.06 (3C, C(CH3)3), 14.08 (OCH2CH3); FT–IR
m/
e
cmꢀ1 (KBr): 2976, 1739, 1608, 1461, 1391, 1368, 1299, 1260, 1141, 1088, 1040,
890, 857, 578, 527; UV–vis (CHCl3) kmax (nm): (log
e) 258 (5.00), 314 (4.52), 427
18. (a) Russowsky, D.; da Silveira Neto, B. A. Tetrahedron Lett. 2004, 45, 1437; (b)
Neto, B. A. D.; Lapis, A. A. M.; Bernd, A. B.; Russowsky, D. Tetrahedron 2009, 65,
2484.
(3.40), 456 (3.21); MS (ꢀESI): m/z 1051 (Mꢀ). Compound 5c: 1H NMR
(300 MHz, CDCl3) d 5.78 (s, 1H), 4.42–4.32 (m, 8H), 1.42 (t, J = 7.1 Hz, 6H),
1.41 (t, J = 7.1 Hz, 6H); 13C NMR (75 MHz, CS2/CDCl3, with Cr(acac)3 as
19. Lacroix, S.; Rixhon, V.; Marchand-Brynaert, J. Synthesis 2006, 2327.
relaxation reagent) (all 2C unless indicated)
d 173.59 (1C, C@N), 165.98